{"id":23735,"date":"2022-11-22T14:30:54","date_gmt":"2022-11-22T12:30:54","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=23735"},"modified":"2022-11-22T14:30:54","modified_gmt":"2022-11-22T12:30:54","slug":"atnaujinamas-skiepijimas-pagal-pirmine-schema-5-11-metu-amziaus-vaikams","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2022\/11\/22\/atnaujinamas-skiepijimas-pagal-pirmine-schema-5-11-metu-amziaus-vaikams\/","title":{"rendered":"Atnaujinamas skiepijimas pagal pirmin\u0119 schem\u0105 5\u201311 met\u0173 am\u017eiaus vaikams"},"content":{"rendered":"<p><strong>Nuo \u0161ios savait\u0117s atnaujinamas skiepijimas nuo COVID-19 pagal pirmin\u0119 schem\u0105 5-11 met\u0173 am\u017eiaus vaikams. \u0160iuo metu Ekstremali\u0173 sveikatai situacij\u0173 centro sand\u0117liuose atve\u017eta 9600 Comirnaty vakcin\u0173, kurias asmens sveikatos prie\u017ei\u016bros \u012fstaigos gal\u0117s u\u017esakyti ir v\u0117l t\u0119sti vaik\u0173 skiepijim\u0105.<\/strong><\/p>\n<p>Vakcinuojant pagal piln\u0105 schem\u0105, 5\u201311 met\u0173 am\u017eiaus vaikai gali b\u016bti skiepijami ma\u017eesnio t\u016brio \u201eComirnaty\u201c (gamintojas \u201eBioNTech ir Pfizer\u201c) vakcina (dviem doz\u0117mis, 21 d. skirtumu), nuo 6 met\u0173 am\u017eiaus gali b\u016bti naudojama ir \u201eSpikevax\u201c vakcina, suleid\u017eiant pus\u0119 \u012fprastos vakcinos doz\u0117s du kartus, 28 dien\u0173 skirtumu.<\/p>\n<p>Vaikai nuo 12 met\u0173 am\u017eiaus \u0161iuo metu gali pasiskiepyti \u201eComirnaty\u201c (gamintojas \u201eBioNTech ir Pfizer\u201c, skiepijama dviem doz\u0117mis, 21 d. skirtumu) arba \u201eSpikevax\u201c\u00a0 (gamintojas \u201eModerna\u201c, skiepijama dviem doz\u0117mis, 28 d. skirtumu) vakcinomis.<\/p>\n<p>Anot SAM Sveikatos stiprinimo skyriaus patar\u0117jos Ginretos Megelinskien\u0117s, lapkri\u010dio 18 d. duomenimis, Lietuvoje pagal piln\u0105 schem\u0105 paskiepyt\u0173 5\u201311 m. am\u017eiaus vaik\u0173 yra 6712 (3,30 proc.), 12\u201315 m. \u2013 28523 (24,51 proc.), sustiprinan\u010di\u0105ja doze pasiskiepijusi\u0173 5\u201311 m. vaik\u0173 \u2013 756 (0,65 proc.).<\/p>\n<p>Gruod\u017eio prad\u017eioje planuojama sustiprinan\u010di\u0105ja COVID-19 doze prad\u0117ti skiepyti ir 6 m\u0117n.\u20134 m. am\u017eiaus vaikus. Vakcin\u0173 doz\u0117s \u0161ioje am\u017eiaus grup\u0117je bus ma\u017eesn\u0117s.<\/p>\n<p>Ministerija atkreipia d\u0117mes\u012f, kad registracija vakcinacijai numeriu 1808 Lietuvoje jau nebevykdoma. U\u017esiregistruoti sustiprinamajai vakcinos nuo COVID-19 dozei galima dviem b\u016bdais: internetu \u2013 internetin\u0117je svetain\u0117je\u00a0<a href=\"file:\/\/\/C:\/%5C%5CUsers%5C%5Cmikenaite%5C%5CAppData%5C%5CLocal%5C%5CMicrosoft%5C%5CWindows%5C%5CINetCache%5C%5CContent.Outlook%5C%5CPR086DKW%5C%5Ckoronastop.lt\">koronastop.lt<\/a>, prisijungus per elektroninius vald\u017eios vartus, pasirinkus skiepijimo viet\u0105 ir laik\u0105, arba telefonu kreipiantis \u012f savo arba kit\u0105 gydymo \u012fstaig\u0105, kurioje pageidaujama skiepytis.<\/p>\n<p>Skiepijimui \u0161eimos gydytojo siuntimas nereikalingas, ta\u010diau norint pasikonsultuoti d\u0117l skiep\u0173, gyventojams rekomenduojama kreiptis \u012f savo asmens sveikatos prie\u017ei\u016bros \u012fstaig\u0105. Taip pat konsultacijoms galima kreiptis \u012f Nacionalin\u012f visuomen\u0117s sveikatos centr\u0105 prie SAM bendruoju konsultacij\u0173 numeriu (8 5) 264 96 76, (konsultuojama I\u2013V 8:00\u201317:00, V 8:00\u201315.45).<\/p>\n<p><a href=\"https:\/\/sam.lrv.lt\/lt\/kontaktai-ziniasklaidai\">SAM Spaudos tarnyba<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nuo \u0161ios savait\u0117s atnaujinamas skiepijimas nuo COVID-19 pagal pirmin\u0119 schem\u0105 5-11 met\u0173 am\u017eiaus vaikams. \u0160iuo metu Ekstremali\u0173 sveikatai situacij\u0173 centro sand\u0117liuose atve\u017eta 9600 Comirnaty vakcin\u0173, kurias asmens sveikatos prie\u017ei\u016bros \u012fstaigos gal\u0117s u\u017esakyti ir v\u0117l t\u0119sti vaik\u0173 skiepijim\u0105. Vakcinuojant pagal piln\u0105 schem\u0105, 5\u201311 met\u0173 am\u017eiaus vaikai gali b\u016bti skiepijami ma\u017eesnio t\u016brio \u201eComirnaty\u201c (gamintojas \u201eBioNTech ir Pfizer\u201c)&hellip;<\/p>\n","protected":false},"author":3,"featured_media":23736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[6],"tags":[],"class_list":["post-23735","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-naujienos","category-6","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-6aP","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2022\/11\/20748_d5a7fc10a6b004d94a2e1e98554da4ce.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/23735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=23735"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/23735\/revisions"}],"predecessor-version":[{"id":23737,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/23735\/revisions\/23737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/23736"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=23735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=23735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=23735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}